Link to Otsuka Global
This is a spacer image
Contact Us
Grants Department




Font Size:
Home About OPDC Press Releases Therapeutic Categories Careers OAPI OMML Contact Us Search Site Map
OPDC Contact Us

Thank you for your interest in OPDC. We're happy to answer questions about our company, and you can also find additional information on our website by clicking on these topics:

Please note that we cannot provide answers to personal medical questions. To obtain such answers you should contact your healthcare provider. Also note that this system is not designed to respond to product complaints.

For questions/comments regarding ABILIFY® (aripiprazole) Tablets1, call Bristol Myers Squibb, Co. at (800) 321-1335 toll-free.

For questions/comments regarding PLETAL® (cilostazol) Tablets2, call Otsuka's Medical Affairs Department at (800) 441-6763 toll free.

For questions/comments regarding BreathTekTM Urea Breath Test (UBT) for H. pylori Kits3 call (888) 637-3835 toll free

For questions/comments regarding IV Busulfex® (busulfan) Injection4 call (800) 438-6414 toll free

For questions/comments regarding SAMSCATM (tolvaptan)5 call (877) 7267220 toll free.

For information regarding Otsuka's Polycystic Kidney Disease clinical trials, call (866) 712-5837

We are not currently enrolling additional patients in Otsuka's Hyponatremia clinical trials, however, please continue to monitor www.clinicaltrials.gov for future information

We are not currently enrolling additional patients in Otsuka's Dry Eye clinical trials, however, please continue to monitor www.clinicaltrials.gov for future information

Corporate Headquarters/General Inquiries
Otsuka Pharmaceutical Development & Commercialization, Inc.
Princeton, NJ 08540
(609) 452-2922 phone
(609) 452-0794 fax

Additional Location:
Rockville, MD 20850
(301) 417-0900 phone (800) 438-6124 toll free
(301) 990-0036 fax

Career Information/Resumes
Human Resources

Media Contact/Public Relations (U.S.)
 Corporate Communications or by mail to:
Corporate Communications
Otsuka America Pharmaceutical, Inc.
2440 Research Boulevard  Rockville, MD 20850 USA

OAPI Medical Information
(800) 441-6763

Questions About Otsuka Pharmaceutical Products (U.S. Residents Only)
Product Information

 

 

 

1 Please see FULL PRESCRIBING INFORMATION including Boxed WARNINGS for ABILIFY.

2 Please see FULL PRESCRIBING INFORMATION including Boxed WARNING for PLETAL.

3 Please see FULL PRESCRIBING INFORMATION for BreathTek.

4 Please see FULL PRESCRIBING INFORMATION including Boxed WARNING for IV BUSULFEX. 

5 Please see FULL PRESCRIBING INFORMATION including Boxed WARNING for SAMSCA.

 



* OAPI, OPDC and OMML are subsidiaries of Otsuka America, Inc. (OAI), a holding company established in the U.S. in 1989. OAI is wholly owned by Otsuka Pharmaceutical Co., Ltd.

0109W-0602